BenQ Medical Technology (ROCO:4116) Cyclically Adjusted Book per Share: NT$28.66 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4116 BenQ Medical Technology Corp ROCO:4116
86 GF Score
Price NT$40.05
GF Value NT$55.15
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is BenQ Medical Technology Cyclically Adjusted Book per Share?

BenQ Medical Technology ROCO:4116 +0.25% 86 Cyclically Adjusted Book per Share is NT$28.66 as of Jun. 2026. GuruFocus rates ROCO:4116 with a GF Score™ of 86/100 and a GF Value™ of NT$55.15 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BenQ Medical Technology's adjusted book value per share for the three months ended in Jun. 2026 was NT$24.739. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$28.66 for the trailing ten years ended in Jun. 2026.

During the past 12 months, BenQ Medical Technology's average Cyclically Adjusted Book Growth Rate was 1.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BenQ Medical Technology was 3.90% per year. The lowest was 3.90% per year. And the median was 3.90% per year.

As of today (2026-09-01), BenQ Medical Technology's current stock price is NT$40.05. BenQ Medical Technology's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$28.66. BenQ Medical Technology's Cyclically Adjusted PB Ratio of today is 1.40.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BenQ Medical Technology was 3.59. The lowest was 1.29. And the median was 1.94.


BenQ Medical Technology  (ROCO:4116) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BenQ Medical Technology's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=40.05/28.66
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BenQ Medical Technology was 3.59. The lowest was 1.29. And the median was 1.94.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BenQ Medical Technology Cyclically Adjusted Book per Share Related Terms


BenQ Medical Technology Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BenQ Medical Technology's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BenQ Medical Technology Cyclically Adjusted Book per Share Chart

BenQ Medical Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 25.14 26.72 27.73 28.17

BenQ Medical Technology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 28.39 28.17 28.49 28.66

ROCO:4116 vs ISRG, BDX, RMD: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BenQ Medical Technology Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BenQ Medical Technology's Cyclically Adjusted PB Ratio falls into.


ROCO:4116
86GF Score
BenQ Medical Technology Corp ROCO:4116
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BenQ Medical Technology Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BenQ Medical Technology's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=24.739/333.9520*333.9520
=24.739

Current CPI (Jun. 2026) = 333.9520.

BenQ Medical Technology Quarterly Data

Book Value per Share CPI Adj_Book
201609 22.247 241.428 30.773
201612 22.541 241.432 31.179
201703 22.552 243.801 30.891
201706 22.270 244.955 30.361
201709 22.396 246.819 30.302
201712 22.821 246.524 30.914
201803 22.943 249.554 30.702
201806 22.302 251.989 29.556
201809 22.641 252.439 29.952
201812 23.263 251.233 30.922
201903 23.734 254.202 31.180
201906 22.638 256.143 29.515
201909 23.044 256.759 29.972
201912 23.566 256.974 30.625
202003 23.732 258.115 30.705
202006 22.555 257.797 29.218
202009 22.890 260.280 29.369
202012 23.650 260.474 30.322
202103 23.763 264.877 29.960
202106 22.832 271.696 28.064
202109 23.019 274.310 28.024
202112 23.293 278.802 27.901
202203 24.798 287.504 28.804
202206 25.567 296.311 28.815
202209 26.355 296.808 29.653
202212 33.479 296.797 37.670
202303 25.314 301.836 28.007
202306 25.670 305.109 28.097
202309 23.914 307.789 25.947
202312 24.679 306.746 26.868
202403 23.216 312.332 24.823
202406 23.886 314.175 25.390
202409 24.637 315.301 26.094
202412 25.177 315.605 26.641
202503 24.081 319.799 25.147
202506 23.673 322.561 24.509
202509 24.476 324.800 25.166
202512 25.281 324.054 26.053
202603 23.501 330.213 23.767
202606 24.739 333.952 24.739

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$28.66 mean?
BenQ Medical Technology (ROCO:4116) has a Cyclically Adjusted Book per Share of NT$28.66 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BenQ Medical Technology and its competitors.
Is BenQ Medical Technology's Cyclically Adjusted Book per Share too high?
BenQ Medical Technology's current Cyclically Adjusted Book per Share is NT$28.66. Overall, BenQ Medical Technology has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Cyclically Adjusted Book per Share compare to ISRG and BDX?
BenQ Medical Technology's Cyclically Adjusted Book per Share of NT$28.66 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BenQ Medical Technology and its competitors. BenQ Medical Technology's current Cyclically Adjusted Book per Share is NT$28.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$55.15, compared to a current price of NT$40.05 — trading 27.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$28.66. BenQ Medical Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Cyclically Adjusted Book per Share is NT$28.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?

Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued. The current stock price of NT$40.05 is trading 27.4% below its estimated GF Value™ of NT$55.15. GuruFocus considers BenQ Medical Technology to be Modestly Undervalued.

Key valuation signals for ROCO:4116:

  • Cyclically Adjusted Book per Share: NT$28.66
  • GF Value™: NT$55.15 vs. price of NT$40.05 (27.4% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BenQ Medical Technology Business Description

Address No.46, Zhouzi Street, 7th Floor, Neihu District, Taipei, TWN, 11493
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
86GF Score

Get the complete analysis for ROCO:4116

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$40.05
Price
NT$55.15
GF Value